AI Airlock Sandbox Pilot Programme Report

AI Summary

The AI Airlock programme report, published by the UK Medicines and Healthcare products Regulatory Agency (MHRA), details findings from a pilot regulatory sandbox focused on Artificial Intelligence as a Medical Device (AIaMD). Throughout the programme's evaluation period, the MHRA examined four pilot case studies to identify technical and regulatory gaps. The main issues identified involve the limitations of traditional medical device regulations when applied to iterative AI models, specifically regarding data quality, clinical safety evidence, and post-market performance monitoring. Operating within the UK's medical device regulatory framework, the report highlights the need for a more agile oversight system. Required actions include updating regulatory support frameworks, developing new assessment methodologies for evolving software, and fostering closer collaboration between innovators and regulators to ensure safety standards keep pace with technological advancement. These recommendations aim to modernize the oversight of AI healthcare technologies and provide a clearer path for developers navigating the UK market while maintaining patient safety.